QUAD Investment Management logo

QUAD Investment Management

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

QUAD Investment Management is an investment firm.

Investor Profile

QUAD Investment Management has made 10 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (30%)
  • Series D (20%)
  • Series C (20%)
  • Post Ipo Equity (10%)
  • Series E (10%)
  • Series A (10%)

Country Focus

  • United States (70%)
  • South Korea (20%)
  • Singapore (10%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Medical
  • Health Care
  • Mhealth
  • Pharmaceutical
  • Software
  • Business Development
  • Biopharma
  • Cannabis
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does QUAD Investment Management frequently co-invest with?

Shanda Group
North America, California, United States, Menlo Park
Co-Investments: 2
SoftBank Vision Fund
Europe, England, United Kingdom, London
Co-Investments: 2
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Pilot House Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
Temasek Holdings
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Sarissa Capital Management
North America, Connecticut, United States, Greenwich
Co-Investments: 2
FM
Europe, Stirling, United Kingdom, Stirling
Co-Investments: 2
Jazz Venture Partners
North America, California, United States, San Francisco
Co-Investments: 3
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 2
Neuberger Berman
North America, New York, United States, New York
Co-Investments: 2

Which angels does QUAD Investment Management often collaborate with?

David Baszucki
North America, California, United States, San Mateo
Shared Deals: 1

What are some of recent deals done by QUAD Investment Management?

NeoCannBio

Seoul, Seoul-t'ukpyolsi, South Korea

NeoCannBio offers natural product processing for natural goods and has created a hemp and medical cannabis cannabinoid library.

BiopharmaCannabisHealth Care
Series BSep 26, 2023
Amount Raised: $7,383,838
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series EApr 25, 2023
Amount Raised: $106,500,000
Good Food For Good

Seoul, Seoul-t'ukpyolsi, South Korea

Good Food For Good operates as a food & lifestyle brand company.

Food and BeverageLifestyle
Series ADec 5, 2022
Amount Raised: $22,982,213
Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Post Ipo EquityDec 6, 2021
Amount Raised: $125,000,000
Akili Interactive Labs

Boston, Massachusetts, United States

Akili Interactive Labs Provides Healthcare Treatments.

BiotechnologyHealth CareMedicalNeuroscienceService IndustryTherapeutics
Series DMay 26, 2021
Amount Raised: $110,000,000
Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Series DDec 8, 2020
Amount Raised: $80,000,000
4D Molecular Therapeutics

Emeryville, California, United States

4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

BiotechnologyGenetics
Series CJun 16, 2020
Amount Raised: $75,000,000
Curiox Biosystems

Singapore, Central Region, Singapore

Curiox Biosystems is a bioinstrumentation company spun out of the Agency for Science, Technology, and Research (A*STAR) in Singapore.

BiotechnologyMedical Device
Series BOct 16, 2019
Amount Raised: $15,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series CSep 23, 2019
Amount Raised: $16,600,000
Oncorus

Cambridge, Massachusetts, United States

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

BiotechnologyMedicalOncologyTherapeutics
Series BAug 21, 2019
Amount Raised: $79,500,000